Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19.8Revenue $M0.6Net Margin (%)-2,778.7Altman Z-Score-22.8
Enterprise Value $M15.5EPS $-1.1Operating Margin %-2,690.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score0.3Pre-tax Margin (%)-2,778.4Higher ROA y-yY
Price/Book5.310-y EBITDA Growth Rate %--Quick Ratio2.8Cash flow > EarningsY
Price/Sales24.85-y EBITDA Growth Rate %--Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-120.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-241.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.0ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BIOC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BIOC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BIOC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wilson Margaret FayeDirector 2015-02-13Buy4,000$1.25-20.8view
ROYSTON IVORDirector 2015-02-13Buy12,000$1.25-20.8view
Neff Edward A.Director 2015-02-13Buy40,000$1.25-20.8view
Nall Michael W.CEO & President 2015-02-13Buy12,000$1.25-20.8view
HUEBNER BRUCE ADirector 2015-02-13Buy12,000$1.25-20.8view
HALE DAVID FChairman 2015-02-13Buy40,000$1.25-20.8view
Gerhardt BruceDirector 2015-02-13Buy20,000$1.25-20.8view
Chandler Marsha AlpertDirector 2015-02-13Buy2,000$1.25-20.8view
BERG JEFFREY HDirector 2012-03-07Sell5,000$5.55-82.16view
LoCastro MarcellaDirector 2011-12-16Buy1,500$4.49-77.95view

Quarterly/Annual Reports about BIOC:

    News about BIOC:

    Articles On GuruFocus.com
    Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 

    More From Other Websites
    BIOCEPT INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Apr 29 2016
    Biocept, Inc. Announces Pricing Of $5 Million Public Offering Of Common Stock And Warrants Apr 29 2016
    8:59 am Biocept prices 5 mln common stock offering at $1.00/share Apr 29 2016
    Biocept, Inc. Announces Pricing Of $5 Million Public Offering Of Common Stock And Warrants Apr 29 2016
    Biocept Inc. Announces Proposed Public Offering Of Common Stock And Warrants Apr 28 2016
    Biocept Collaborates with MedStar Georgetown University Hospital for Liquid Biopsy Study Apr 27 2016
    Biocept Collaborates with MedStar Georgetown University Hospital for Liquid Biopsy Study Apr 27 2016
    Biocept Continues International Expansion through Agreement with Quest Diagnostics Mexico Apr 18 2016
    Biocept Continues International Expansion through Agreement with Quest Diagnostics Mexico Apr 18 2016
    Biocept to Present at the 15th Annual Needham Healthcare Conference Apr 06 2016
    Biocept to Present at the 15th Annual Needham Healthcare Conference Apr 06 2016
    Biocept Forms Clinical Advisory Board of World-Renowned Oncologists Mar 30 2016
    Biocept Forms Clinical Advisory Board of World-Renowned Oncologists Mar 30 2016
    Biocept's Mark Foletta Honored with CFO Lifetime Achievement Award Mar 23 2016
    Biocept to Collaborate on Biopharma Company Clinical Trial by Identifying Biomarkers Found in... Mar 21 2016
    Biocept to Collaborate on Biopharma Company Clinical Trial by Identifying Biomarkers Found in... Mar 21 2016
    BIOCEPT INC Financials Mar 16 2016
    Biocept, Inc. :BIOC-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 14 2016
    BIOCEPT INC Files SEC form 10-K, Annual Report Mar 10 2016
    Progenetics to Distribute Biocept's Liquid Biopsy Assays in Israel Mar 10 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)